Complete is an upper arm blood pressure (BP) monitor that allows users to simultaneously monitor EKG and blood pressure readings at home.
U.S: Omron Healthcare, Inc., the global leader in personal heart health and wellness technology, has secured USFDA clearance on its new Complete™, the first blood pressure monitor with EKG capability in a single device, and will open pre-orders on April 15th at 12:00 pm EST in the U.S. on OmronHealthcare.com.
Complete is an upper arm blood pressure monitor that allows users to simultaneously monitor EKG and blood pressure readings at home. EKG readings can be measured by touching electrodes conveniently located on the top face and both sides of the monitor for easy access and comfort. EKG is an essential measurement for those with atrial fibrillation, also known as arrythmia or Afib, a condition causing an irregular heartbeat that can lead to heart health-related complications, including increased risk of stroke and heart failure.
Commenting on the same, Ranndy Kellogg, president & CEO of Omron Healthcare, Inc. said, “Millions of Americans are living with Afib and a stroke risk that is five times higher than average, and many others may not know they have this condition since it is difficult to diagnose. Recent studies predict that the number of individuals with Afib could reach epidemic levels as a result of the growing aging Baby Boomer population. Monitoring this condition and the risk it carries is part of our Going for Zero mission. That’s why Omron developed Complete as an accessible, easy-to-use, at-home solution to provide a more complete heart health picture and greater peace of mind.”
Omron developed Complete in partnership with AliveCor, the market leader in FDA-cleared personal EKG technology. Complete uses the advanced new algorithm designed by AliveCor for improved detection of the possibility of Afib along with trusted medical-grade blood pressure measurement from Omron.
“Irregular heartbeat is unpredictable and can be difficult to detect without regular monitoring. The Omron Complete empowers anyone who suspects they might have arrythmia or has family history of the condition to monitor their status easily at home,” Kellogg added.
Complete is the recent recipient of the iF Design Award 2019, presented by iF International Forum Design GmbH, one of the world’s most prestigious design awards. This award was presented to Complete for its uniqueness, innovation, aesthetic appearance and performance.
Complete will be available for $199.99 (USD) pre-order only in the U.S. on OmronHealthcare.com, with retail availability expanding to Amazon beginning May 1, 2019.
Latest posts by Farhat Nasim (see all)
- Glenmark Pharma gets USFDA approval for generic version of VAGIFEM - April 25, 2019
- Monarch eTNS: First medical device for treating ADHD gets USFDA approval - April 25, 2019
- Indoco Remedies: USFDA retains OAI status for Goa plant - April 25, 2019